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the proportion of cases with hypertensive cardiomyopathy is of only
15% [6].
After exploring the clinical characteristics of the patients studied
by Bestetti et al. [1], it was found that data related to a higher risk for
malignant arrhythmias were more present in the chagasic group than
in the hypertensive group, such as the occurrence of ventricular
premature complexes (46% versus 18%, p b 0.005), and the necessity
for the use of amiodarone (39% versus 19%, p b 0.005) and of an
implanted cardioverter-deﬁbrillator (16% versus 0.7%, p b 0.001),
despite a similar left ventricular ejection fraction (35% ± 13% versus
36% ± 10%, ns).
In conclusion, I do believe that the main reason for the poorer
outcome in patients with CHF due to Chagas heart disease, in
comparison to those with CHF secondary to hypertensive cardiomyo-
pathy and similar left ventricular ejection fractions, is the occurrence of
malignant ventricular arrhythmias leading to SCD in chagasic patients.
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To target preventive measures appropriately in early life, it is
important to know what childhood cardiovascular (CVD) risk proﬁles
mean in terms of predicting adult risk. Studies from high-income
countries have reported tracking of individual risk factors from
childhood to adulthood [1–7]; there are no reports of child–adult
tracking in low- and middle-income countries (LMICs). The Pune
Children's Study is a cohort of 477 individuals born in the KEM
Hospital, Pune, India in 1987–1989. We measured a range of CVD risk
factors at 8 [8] (1996–7) and 21 (2009–11) years of age, using similar
methods, providing the ﬁrst opportunity to assess child–adult
tracking in a LMIC. Ethical permission was obtained from the KEM
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Hospital Ethics Committee and informed consent was obtained from
all the participants.
Weight was measured to the nearest 5 g, and height and waist
circumference to the nearest 0.1 cm. Biceps, triceps, subscapular and
suprailiac skinfolds were measured to the nearest 0.2 mm using
calipers. Blood pressure was measured supine using a digital monitor;
the average of two readings made 5 min apart was used for analysis.
Fasting venous blood was drawn for plasma lipid, glucose, insulin
and leptin measurements. An oral glucose tolerance test was
performed giving 1.75 g/kg (8 years) and 75 g (21 years) anhydrous
glucose in water, followed by a 120-minute blood sample (WHO
protocol). Plasma glucose, cholesterol, HDL-cholesterol, and triglycer-
ide concentrations were measured using standard enzymatic meth-
ods. Plasma insulin and leptin were measured using an
immunoenzymometric assay and RIA respectively at 8 years, and a
Delﬁa technique and ELISA at 21 years. Insulin resistance (HOMA-IR)
was calculated at both ages using the online Oxford model (http://
www.dtu.ox.ac.uk). Overweight was deﬁned as BMI ≥ 25 kg/m2 and
b30 kg/m2, obesity as BMI ≥ 30 kg/m (WHO criteria) and central
obesity as waist circumference≥90 cm inmen and≥80 cm inwomen
(IDF criteria). Hypertension was deﬁned as systolic blood pressure
≥130 mm Hg or diastolic blood pressure ≥85 mm Hg (IDF criteria).
Impaired fasting glucose (IFG) was deﬁned as fasting glucose
≥100 mg/dl and b126 mg/dl, impaired glucose tolerance (IGT) as
120-minute glucose ≥140 mg/dl and b200 mg/dl, and diabetes
mellitus (DM) as fasting glucose ≥126 mg/dl or 120-minute plasma
glucose ≥200 mg/d (ADA criteria). Hypercholesterolaemia was
deﬁned as total cholesterol ≥200 mg/dl (NCEP criteria), hypertrigly-
ceridaemia as triglycerides ≥150 mg/dl, and low HDL-cholesterol as
HDL-cholesterol b40 mg/dl for men and b50 mg/dl for women (IDF
criteria).
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Statistical methods: We assessed tracking between the two
ages using Pearson correlation coefﬁcients. We categorized each risk
factor by quartiles and calculated the relative risk of persisting in the
highest or lowest categories between 8 and 21 years. We assessed the
agreement between category status at the two ages using Cohen's
kappa statistic. We calculated sensitivity, speciﬁcity, and positive and
negative predictive values for being in the highest risk category
at 8 years and disease outcomes at 21 years (overweight/obesity,
central obesity, hypertension, dyslipidaemia, hyperglycemia). Statis-
tical analyses were performed using SPSS 16.0.
Of 477 children studied at 8 years, 357 (75%) participated at
21 years (191 males). Non-participants had higher 8-year BMI
(p =0.05) and larger 8-year subscapular (p = 0.03), triceps
(p = 0.02), and biceps (p = 0.05) skinfolds but similar values for all
other measurements compared to participants. Of the participants,
18.5% were overweight, 2.5% were obese, 4.8%were hypertensive, 5.6%
had hypercholesterolaemia, 7.6% had hypertriglyceridaemia, and
69.3% had low HDL-cholesterol at 21 years. Three participants were
known to have diabetes; a further 18.5% were found to be
hyperglycaemic (11.2% IFG, 5.9% IGT and 1.4% DM).
All the 8-year measurements were signiﬁcantly positively corre-
lated with their corresponding 21-year measurements, except 120-
minute glucose concentration (Table 1); ﬁndings were similar in both
sexes. Correlation coefﬁcients for the age- and sex-adjusted values
ranged from r = 0.53 (total cholesterol and BMI) to r = 0.14 (fasting
insulin and HOMA-IR) (p b 0.05 for all). They were also similar using
BMI-adjusted variables.
The risk of an individual being in the highest-risk category at
21 years was increased if they were in the same category at 8 years;
these associations were strongest for cholesterol and BMI andweakest
for fasting insulin, glucose and systolic blood pressure (Table 1). There
was a similar tendency to persist in the lowest-risk category between
8 and 21 years. The strength of tracking showed similar results; the
closest agreement between categories at 8 and 21 years was observed for
cholesterol (Cohen's kappa= 0.36), while the weakest was observed for
120-minute glucose (Cohen's kappa= 0.06).
Positive predictive values of being in the high-risk group at 8 years for
developing disease outcomes ranged from 73% (low HDL-cholesterol) to
8% (hypertension) (Table 2). Negative predictive values ranged from 98%
(hypercholesterolaemia) to 32% (lowHDL-cholesterol). Sensitivity values
were less than 50% except for hypercholesterolaemia (75%). Speciﬁcity
values were 70–80%.
These are the ﬁrst data on child–adult tracking of a range of
CVD risk factors from a LMIC.We found signiﬁcant tracking for all risk
factors, similar in both sexes. Measures of adiposity (BMI, skinfolds,
waist circumference) and total cholesterol showed strong tracking.
Intermediate tracking effects were seen for blood pressure, triglycer-
ides, HDL-cholesterol, fasting glucose and insulin resistance while
tracking was weakest for 120-minute glucose concentrations.
Our ﬁndings are consistent with studies from high-income
countries [4–7]. Tracking may occur due to persistence of environ-
mental factors through childhood and into adulthood. A meta-
analysis showed that dietary behavior and physical activity tracks
from childhood into adulthood [9]. As both are modiﬁable factors, it
suggests interveningearlier in the lifecoursemay bebeneﬁcial. Tracking
may also be due to genetic factors. Another possible reason could be
‘programming’ of risk factors during early life, andmay suggest stability
of epigenetic changes established earlier. Our previous ﬁnding linking
birthweight to insulin resistance at four years [10] supports this
possibility adding weight to interventions before and during pregnancy
to improve fetal growth.
Despite signiﬁcant correlations of child and adult risk factors,
predictive values do not support their use as screening tools. This
suggests that measures to reduce risk factors in children should be
Table 1
Tracking of CVD parameters from childhood to young adulthood.
8 to 21 years (n = 354)
Age and sex speciﬁc variables r (p-value) % in highest fourth of the
distribution at 8 who
remained there at 21 y
Relative risk (95%CI) % in lowest fourth of the
distribution at 8 who
remained there at 21 y
Relative risk (95% CI) Cohen's kappa
(p-value)
BMI 0.53 (b0.001) 50.6 2.87 (2.05, 4.01) 47.7 2.86 (2.02, 4.05) 0.33 (b0.001)
Height 0.44 (b0.001) 43.4 2.43 (1.70, 3.46) 44.9 2.36 (1.68, 3.31) 0.23 (b0.001)
Waist circumference 0.44 (b0.001) 48.3 2.67 (1.91, 3.74) 40.9 2.12 (1.49, 3.02) 0.28 (b0.001)
Sum of skinfolds 0.44 (b0.001) 49.4 2.80 (2.00, 3.93) 47.7 2.73 (1.94, 3.85) 0.31 (b0.001)
Systolic BP 0.21 (b0.001) 31.3 1.37 (0.93, 2.02) 30.6 1.37 (0.93, 2.03) 0.07 (0.03)
Diastolic BP 0.28 (b0.001) 35.3 1.64 (1.13, 2.38) 25.3 1.00 (0.66, 1.53) 0.14 (b0.001)
Cholesterol 0.53 (b0.001) 57.5 4.19 (2.94,5.97) 49.4 2.88 (2.05, 4.06) 0.36 (b0.001)
Triglycerides 0.33 (b0.001) 37.4 1.79 (1.25, 2.56) 40.2 2.07 (1.45, 2.96) 0.22 (b0.001)
HDL-cholesterol 0.26 (b0.001) 36.0 1.64 (1.14,2.35) 38.9 1.94 (1.36, 2.77) 0.18 (b0.001)
Fasting glucose 0.17 (0.006) 32.2 1.47 (1.00,2.15) 31.0 1.37 (0.93, 2.01) 0.07 (0.03)
120-minute glucose 0.07 (0.15) 27.4 1.20 (0.79, 1.82) 30.5 1.30 (0.87, 1.93) 0.06 (0.06)
Fasting insulin 0.14 (0.009) 28.4 1.18 (0.79, 1.77) 32.1 1.46 (1.00, 2.15) 0.08 (0.02)
HOMA-IR 0.14 (0.006) 35.6 1.65 (1.14, 2.38) 33.7 1.58 (1.08, 2.32) 0.11 (0.002)
Leptin 0.24 (b0.001) 40.5 1.99 (1.37, 2.87) 39.0 1.86 (1.27, 2.69) 0.23 (b0.001)
BMI: body mass index; BP: blood pressure; IR: insulin resistance.
Table 2
Positive and negative predictive values, sensitivity and speciﬁcity of childhood risk categories for disease outcomes at young adulthood.
Upper fourth risk category at 8 years Disease outcome at 21 years Positive predictive value Negative predictive value Sensitivity Speciﬁcity
BMI Overweight/Obesity 42% 85% 48% 82%
Waist circumference Central obesity 43% 82% 44% 81%
Systolic BP Hypertension 8% 96% 43% 76%
Diastolic BP Hypertension 8% 96% 43% 76%
Cholesterol Hypercholesterolaemia 17% 98% 75% 78%
Triglycerides Hypertriglyceridaemia 14% 94% 50% 76%
HDL-cholesterol Low HDL 73% 32% 26% 78%
Fasting glucose Hyperglycaemia 26% 83% 33% 77%
BMI: body mass index; BP: blood pressure.
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public health interventions, such as encouraging regular physical
activity and healthier diets, rather than individually targeted
interventions.
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It is widely reported that the natural history of rheumatic heart
disease (RHD) is more aggressive in developing countries, manifesting
symptoms and requiring interventions at a younger age than in
industrialized nations [1–5]. As the demographics in urban America
shift with growing immigrantminorities from Latin America and other
developing countries, it is possible that the demographics and natural
history of RHD in the U.S. are changing as well. We compared the
natural historyanddisease burdenbetween immigrant and indigenous
patients with RHD receiving care at Cook County Health and Hospitals
System, a large public health care network serving inner-city Chicago.
The study was internally funded and approved by the Institutional
Review Board of John H. Stroger, Jr. Hospital of Cook County.
A retrospective cohort study design was implemented. In a query
of electronic health records, we identiﬁed 1257 adult patients with
clinical or echocardiographic documentation of rheumatic valvular
heart disease, heart valve prosthesis, or valvular intervention in the
period between January 1, 2005 and December 31, 2011. A detailed
chart review excluded 1153 subjects with valvular surgeries for
indications other than RHD. Review of echocardiographic images of
the remaining 104 patients excluded 13 patients for lacking diagnostic
rheumatic valvular deformity [6]. One patient was lost to follow-up. In
the 90 remaining subjects, the latest echocardiographic examination on
records and the last one prior to valvular intervention (if different) were
reviewed to determine the presence and severity of stenotic and
regurgitant valvular lesions [7,8]. Thepulmonaryarterial systolic pressure
was calculated [9].
Among the 90 subjects included in the study 33 (37%) were im-
migrants, raised and acquired the disease outside the U.S. and 57 (63%)
were indigenous raised and acquired RHD in the U.S. Women
comprised 79% of both groups. All immigrant patients migrated
from developing countries [Latin America (16); East Asia (7); South
Asia (3); Sub-Saharan Africa (3); Middle East (2); East Europe (2)].
African Americans comprised 98% of the indigenous group, which is
signiﬁcantly greater than their proportion in the general echocardio-
graphy laboratory population (81%) [odds-ratio = 13.1, 95% conﬁdence
interval (CI) = 1.8–95.5, P b 0.001].
The study cohort was followed for a mean of 10 ± 8 years (900
patient-years). During follow-up, immigrants had higher event rate of
the primary endpoint of valvular intervention [22 (67%) vs. 25 (44%),
hazard-ratio = 3.0 (CI = 1.6–5.5); P b 0.001] and had their ﬁrst
intervention at younger age, by an average of 11 years. Similarly,
immigrants had a higher rate of the secondary endpoint of sympto-
matic onset of RHD [28 (85%) vs. 35 (61%), hazard-ratio = 2.9
(CI = 1.7–4.8); P b 0.001] and had their symptom onset at younger
age, by an average of 13 years (Fig. 1, Table 1). By age 40 years,
immigrants were more likely to be diagnosed with RHD (33% vs. 14%,
P= 0.03), have symptom onset (33% vs. 9%, P= 0.008), and undergo
valvular interventions (33% vs. 7%, P= 0.02). Immigrants were more
likely to present with atrial ﬁbrillation as a ﬁrst manifestation of the
disease (Table 1).
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